There were 1,648 press releases posted in the last 24 hours and 442,181 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
TESARO and Takeda Enter Into Exclusive Licensing Agreement to Develop and Commercialize Novel Cancer Therapy Niraparib in Japan

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image